These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30254849)

  • 21. [Role of M-type phospholipase A2 receptor and its antibody in hepatitis B virus-associated membranous nephropathy].
    Xu X; Zhu X; Yuan S; Jiang W; Xia Y; Liu H; Li J; Sun L; Peng Y; Liu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1064-1068. PubMed ID: 27807329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.
    Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA.
    Kaga H; Komatsuda A; Yamamoto S; Kikuchi T; Kamata M; Sato A; Odaka M; Yokota SI; Takahashi N; Wakui H
    Clin Exp Nephrol; 2019 Apr; 23(4):465-473. PubMed ID: 30756249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cohort study of membranous nephropathy, primary or secondary.
    Arghiani M; Zamani BH; Nazemian F; Samadi S; Afsharian MS; Habibzadeh M; Eslami S; Sabbagh MG
    BMC Nephrol; 2021 Apr; 22(1):138. PubMed ID: 33874909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy.
    Chen Y; Xu Y; Chen S; Yu Y; Zhu X; Chen J
    Ren Fail; 2023; 45(2):2264939. PubMed ID: 37814415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of Anti-Phospholipase A2 and Anti-Thrombospondin Type 1 Domain-Containing Protein 7A in Latin Patients with Membranous Nephropathy.
    Battaini LC; Ranzani OT; Marçal LJ; Antonangelo L; Jorge LB; Bitencourt CD; Woronik V; Malheiros DMA; Yu L
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
    Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS
    J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.
    Hoxha E; Harendza S; Pinnschmidt H; Panzer U; Stahl RA
    PLoS One; 2014; 9(10):e110681. PubMed ID: 25313791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy.
    Jullien P; Seitz Polski B; Maillard N; Thibaudin D; Laurent B; Ollier E; Alamartine E; Lambeau G; Mariat C
    Clin Kidney J; 2017 Apr; 10(2):209-214. PubMed ID: 28396737
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population.
    Ardalan M; Ghafari A; Hamzavi F; Nasri H; Baradaran B; Majidi J; Nikbin B
    J Nephropathol; 2013 Oct; 2(4):241-8. PubMed ID: 24475456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Clinical Profile and Long-Term Outcome of Children with Membranous Nephropathy, and the Evaluation of Anti-Phospholipase A2 Receptor Antibody Immunohistochemistry in Kidney Biopsy.
    Deepthi RV; George S; Mathew G; Roy S; Bindra M; Rebekah G; Agarwal I
    Indian J Nephrol; 2023; 33(6):432-439. PubMed ID: 38174298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].
    Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to M-type phospholipase A2 receptor (PLA
    Garcia-Vives E; Solé C; Moliné T; Alvarez-Rios AM; Vidal M; Agraz I; Ordi-Ros J; Cortés-Hernández J
    Lupus; 2019 Mar; 28(3):396-405. PubMed ID: 30760090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults.
    Wu X; Liu L; Guo Y; Yang L
    Int J Nephrol Renovasc Dis; 2018; 11():241-247. PubMed ID: 30288080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy.
    Ge YC; Jin B; Zeng CH; Zhang MC; Chen DC; Yin R; Le WB
    BMC Nephrol; 2016 Nov; 17(1):185. PubMed ID: 27876003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-phospholipase A2 receptor antibody screening in nephrotic syndrome may identify a distinct subset of patients with primary membranous nephropathy.
    Jurubiță R; Obrișcă B; Achim C; Micu G; Sorohan B; Bobeică R; Vornicu A; Găman M; Căpușă C; Ștefan G; Viașu L; Mircescu G; Ismail G
    Int Urol Nephrol; 2022 Jul; 54(7):1713-1723. PubMed ID: 34799809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy.
    Teisseyre M; Perrochia H; Reboul P; Cariou S; Renaud S; Aglae C; Moranne O
    BMC Nephrol; 2020 May; 21(1):196. PubMed ID: 32448215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis.
    Li W; Zhao Y
    Int Urol Nephrol; 2019 Sep; 51(9):1581-1596. PubMed ID: 31140029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-phospholipase A2 receptor antibody in membranous nephropathy.
    Qin W; Beck LH; Zeng C; Chen Z; Li S; Zuo K; Salant DJ; Liu Z
    J Am Soc Nephrol; 2011 Jun; 22(6):1137-43. PubMed ID: 21566055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.